ICU Medical, Inc.

ICU Medical, Inc.

ICUI

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.38B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ICU Medical, Inc.ICU Medical, Inc.145.9-2%1.90.6
$184.00

Target Price by Analysts

10.7% upsideICU Medical Target Price DetailsTarget Price
$161.64

Current Fair Value

2.8% downside

Overvalued by 2.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.38 Billion
Enterprise Value$5.32 Billion
Dividend Yield$- (-)
Earnings per Share$0.03
Beta0.75
Outstanding Shares25,000,000

Return

Return on Equity1.78%ROE
Return on Assets0.96%
Return on Invested Capital2.15%

Valuation & Multiples

P/E Ratio145.92P/E Ratio
PEG-317.3PEG
Price to Sales1.93Price to Sales
Price to Book Ratio1.93Price to Book Ratio
Enterprise Value to Revenue2.46
Enterprise Value to EBIT71.24
Enterprise Value to Net Income138
Total Debt to Enterprise0.23
Debt to Equity0.58Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$1.91
Average shareholder expectation
Revenue Estimate
$533.44 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.13
Average shareholder expectation
Revenue Estimate
$552.13 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2216 40.86%
Total Calls68,600 213.24%
Total Puts15,200 10.14%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %122.35% 20.87%
Total Invested$3.89B 20.68%
Investors Holding292 10.00%

ESG Score

No data

About ICU Medical, Inc.

9,000 employees
CEO: Vivek Jain

ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...